IFNB1 and prostate carcinoma: With 0.5 mmol/L of 5-FC, HB1.F3.CD.IFN-β cells inhibited the growth of the prostate cancer cells by 25%; cancer cell viability was slightly reduced by HB1.F3.CD cells.